Hypnotics. Drug selection by means of the system of objectified judgement analysis (SOJA) method

PharmacoEconomics

Volumn 10, Issue 2, 1996, Pages 152-163

  Janknegt, Robert ^a   Van Der Kuy, Ary ^b   Declerck, Guus ^c   Idzikowski, Chris ^d  

^a Zuyderland Medical Centre   (Netherlands)

^b Kempenhaeghe ^*

^c EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^d Lisburn   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNITRAZEPAM; HYPNOTIC AGENT; LOPRAZOLAM; LORMETAZEPAM; NITRAZEPAM; TEMAZEPAM; ZOLPIDEM; ZOPICLONE;

ARTICLE; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG FORMULARY; HUMAN; PRIORITY JOURNAL; SLEEP DISORDER;

EID: 0029761503     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199610020-00007     Document Type: Article

References (69)

1. Springer MP, Eykelenboom PR. Slaapstoornissen, diagnostiek en behandeling door de huisarts. DIMS (Dutch publication of the International of Medical Statistics) 1989; nr8: 4-11
2. Zitman FG. De behandeling van slaapstoornissen met benzodiazepinen. DIMS (Dutch publication of the International of Medical Statistics) 1989; nr 8: 12-7
3. Breemhaar E, Kroesbergen HT, Damen F. Medicijgebruik van ouderen in het land van Heusden en Altena. 1993 GGD Stadsgewest Breda IVA Instituut voor Sociaal Wetenschappelijk Onderzoek Tilburg
4. Danhof M, Breimer DD. Farmacokinetische keuzecriteria van slaapmiddelen. Tijdschr Geneesm Onderz/J Drug Research 1985; 10: 889-94
5. Moleman P. Farmacologische keuzecriteria voor slaapmiddelen. Tijdschr Geneesm Onderz/J Drug Research 1985; 10: 877-81
6. Hoes MJAJM. Klinische keuzecriteria van slaapmiddelen. Tijdschr Geneesm Onderz/J Drug Research 1985; 10: 882-8
7. Van der Kleijn E, Zuidgeest T, Groen M, et al. Keuzecriteria en het gebruik van slaapmiddelen. Tijdschr Geneesm Onderz/J Drug Research 1985; 10: 859-64
8. Oswald I. Criteria for selecting an hypnotic. Tijdschr Geneesm Onderz/J Drug Research 1984; 9: 480-6
9. Dingemanse J. Pharmacotherapy of insomnia: practice and prospects. Pharm World Sci 1995; 17: 67-75
10. Steenhoek A, Janknegt R, Oldenhot HGJ, et al. SOJA systeem: hulp bij belangrijke keuzemomenten in de farmacie. Pharm Weekbl 1988; 123: 75-9
11. Janknegt R. Fluoroquinolones: use of clinical data to aid formulary choice by the System of Objective Judgement Analysis (SOJA) method. PharmacoEconomics 1994; 6: 15-33
12. Jochemsen R, van Boxtel CJ, Hermans J, et al. Kinetics of five benzodiazepine hypnotics in healthy subjects. Clin Pharmacol Ther 1983; 3-4: 42-7
13. Crevoisier C, Ziegler WH, Eckert M, et al. Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. Br J Clin Pharmacol 1983; 16: 51S-61S
14. Morgan K. Hypnotics in the elderly: what cause for concern? Drugs 1990; 40: 688-96
15. Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 1989; 16: 337-64
16. Doenicke A. Klinisch-pharmakologische Aspekte. In: Hergmann H, ed. Benzodiazepine-klinische Bedeutung und Anwendung. Maudrich: Vienna, 1987: 39-59
17. Wadworth AN, McTavish D. Zopiclone: a review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 1993; 3: 441-59
18. Jochemsen R, van Rijn PA, Hazelzet TGM. Assay of midazolam, brotizolam and loprazolam in plasma by a gas chromatography and a radioreceptor technique. In: Jochemsen R. Clinical pharmacokinetics of benzodiazepine hypnotics [thesis]. Leiden: Univ. of Leiden, 1983: 66-77
19. Jochemsen R, Hogendoorn JJH, Dingemanse J, et al. Pharmacokinetics and bioavailability of intravenous, oral and rectal nitrazepam in humans. In: Jochemsen R. Clinical pharmacokinetics of benzodiazepine hypnotics [thesis]. Leiden: Univ. of Leiden, 1983: 97-111
20. Langtry HD, Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 40: 291-313
21. Jochemsen R, van Rijn PA, Hazelzet TGM, et al. Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administration. In: Jochemsen R. Clinical phamacokinetics of benzodiazepine hypnotics [thesis]. Leiden: Univ. of Leiden, 1983: 176-83
22. Knuistingh-Neven A, de Graaf WJ, Lucassen PLEJ, et al. NHG-standaard Slapeloosheid en slaapmiddelen. Huisarts Wet 1992; 35: 212-9
23. Greenblatt DJ. Clinical implications of pharmacokinetic differences among benzodiazepines. Act Med Int Psychiatrie 1985; 2 Suppl. 1: 8-12
24. Jochemsen R, Breimer DD. Pharmacokinetics of benzodiazepine hypnotics in man. Pharm Int 1984; 5: 244-8
25. Declerck AC, Wauqier A. Slaapstoornissen. Weert: M & P, 1986: 126-9
26. van Dongen PAM. Waken en slapen. Tilburg: Janssen Pharmaceutica, 1991
27. Goldenberg F. Implications of changes in sleep architecture induced by hypnotics. JAMA (South East Asian version) 1993 Suppl. 9: 8-12
28. Greenblatt DJ. Clinical applications of pharmacokinetic differences among benzodiazepines. In: Hoes MJAJM, Broers M, Patay M, editors. Clinical differentation of benzodiazepines. 1986: 11-9
29. O'Hanlon JF. Benzodiazepine influence on driving proficiency. In: Hoes MJAJM, Broers M, Patay M, editors. Clinical differentiation of benzodiazepines. 1986: 31-6
30. Loonen AJM. Benzodiazepines; een dankbaar gespreksonderwerp. Pharm Weekbl 1986; 121: 420-8
31. Van der Laan JW. Afhankelijkheid van benzodiazepines, omvang, risico's en eventuele verschillen tussen de middelen onderling. Ned Tijdschr Geneeskd 1984; 128: 809-14
32. Owen RT, Tyrer P. Benzodiazepine dependence: a review of the evidence. Drugs 1983; 25: 385-98
33. Ashton H. Benzodiazepine withdrawal: an unfinished story. BMJ 1984; 288: 1135-40
34. Greenblatt DJ, Shader RJ, Abernethy DR. Current status of benzodiazepines. N Engl J Med 1985; 309 (2 Pt 2): 410-6
35. Sepphia T, Nuotto F, Dreyfuss JF. Drug alcohol interaction on psychomotor skills: zopiclone and flunitrazepam. Pharmacology 1983; 27 Suppl. 2: 127-35
36. Olkkola KT, Aranko K, Luurila H, et al. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993; 53: 298-305
37. Green DS, Dockens RC, Salazar DE. Coadministration of nefazodone and benzodiazepines: I. Pharmacokinetic assessment. Clin Pharmacol Ther 1994; 55: 141
38. Hindmarch I. Assesment of daytime psychomotor performance and memory effects of hypnotic drugs. JAMA (South East Asian edition) 1993; 9 Suppl.: 13-6
39. Informatorium Medicamentorum 1996. The Hague, the Netherlands: Royal Dutch Society of Pharmacy, 1996
40. Allain N, Delahaye C, Le Cox F, et al. Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases. Sleep 1991; 14: 408-13
41. King DJ. Benzodiazepines, amnesia and sedation: theoretical and clinical issues and controversies. Hum Psychopharmac 1992; 7: 79-87
42. Subhan Z, Hindmarch I. Effect of zopiclone and benzodiazepine hypnotics on search in short-term memory. Neuropsychobiology 1984; 12: 244-8
43. Fossen A, Goddibsen OB, Loyning Y, Dreyfus JF. Effects of hypnotics on memory. Pharmacol 1983; 17 Suppl. 2: 116-26
44. Rotenberg VS. Sleep and memory: I. The influence of different sleep stages on memory. Neurosci Biobehav Rev 1992; 16: 497-502
45. Rotenberg VS. Sleep and memory: II. Investigations on humans. Neurosci Biobehav Rev 1992; 16: 503-5
46. Bixler EO, Kales A, Brubaker BH, et al. Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system. Pharmacology 1987; 35: 286-300
47. Schou J. Triazolam: adverse effects in relation to dosage. Pharmacol Toxicol 1989; 64: 6-8
48. Marks J. Techniques of benzodiazepine withdrawal in clinical practice. Med Toxicol 1988; 3: 324-33
49. Smith DE. Benzodiazepine dependence potential: current studies and trends. J Subst Abuse Treat 1984; 1: 163-7
50. Fleischhacker WW, Barnas C, Hackenberg B. Epidemiology of benzodiazepine dependence. Acta Psychiatr Scand 1986; 74: 80-3
51. Marks J. Benzodiazepine dependence in perspective. In: Nicholson AN, ed. Hypnotics in clinical practice. Oxford: Medicine Publishing Foundation, 1982: 67-73
52. Kazamatsuri H. A clinical study on dependence liability of zopiclone [abstract]. 4th International Congress on Sleep Research: 1983; Bologne
53. Boisai K, Dreyfus JF, Delmotte M. Studies on the dependence-inducing potential of zopiclone and triazolam. Pharmacology 1983; 27 Suppl. 2: 242-7
54. Bixler EO, Kales JD, Kales A, et al. Rebound insomnia and elimination half-life: assessment of individual subject response. J Clin Pharmacol 1985; 25: 115-24
55. Gullin JC, Spinweber CL, Johnson LC. Rebound insomnia: a critical review. J Clin Psychopharmacol 1989; 9: 161-72
56. Roehrs T, Volgel G, Roth T. Rebound insomnia: its determinants and significance. Am J Med 1990; 88 Suppl. 3A: 39-42
57. Van Dam JG. Slaapmiddelen en rebound-slapeloosheid: benzodiazepinen en zopiclon. Pharm Weekbl 1991; 126: 116-7
58. Kornaat H. Slaapmiddelen en rebound-slapeloosheid: benzodiazepines en zopiclon II (ingezonden brief). Pharm Weekbl 1991; 126: 555-6
59. Kamphuisen HAC, van Dijk JG. Snurken en het slaapapnoe syndroom. Practitioner 1988; 5: 785-7
60. Phillipson EA. Sleep apnoea: a major public health problem. N Engl J Med 1993; 328: 1271-3
61. Hoes MJAJM. Over Slaapmiddelen: de plaats van Zopiclone. Tijdschr Geneesm Onderz/J Drug Research 1993; 18: 90-4
62. Ranløv PJ, Nielsen SP. Effect of zopiclone and diazepam on ventilatory response in normal human subjects. Sleep 1987; 10 Suppl.: 40-47
63. Van Heijst ANP, Pikaar SA, editors. Vergiftigingen. Utrecht: Scheltema en Holkema, 1988
64. Nicholson AN. Hypnotics: their place in therapeutics. Drugs 1988; 31: 164-76
65. Beckmann H, Haas S. Therapie mit benzodiazepinen: eine Bilanz. Nervenarzt 1984; 55: 111-21
66. Langley MS, Clissold SP. Brotizolam: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 1988; 35: 104-22
67. Clark BG, Jue SG, Dawson GW, et al. Loprazolam: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia. Drugs 1986; 31:500-16
68. Dundee JW, Halliday NJ, Harper KW, et al. Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 1984; 28: 519-43
69. Pakes GE, Brogden RN, Heal RC, et al. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 1981; 22: 91-110